| Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 13180* | 2021 |
| Pancreatic cancer D Li, K Xie, R Wolff, JL Abbruzzese The Lancet 363 (9414), 1049-1057, 2004 | 2717 | 2004 |
| Laser-capture microdissection V Espina, JD Wulfkuhle, VS Calvert, A VanMeter, W Zhou, G Coukos, ... Nature protocols 1 (2), 586-603, 2006 | 893 | 2006 |
| Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays S Nishizuka, L Charboneau, L Young, S Major, WC Reinhold, M Waltham, ... Proceedings of the National Academy of Sciences 100 (24), 14229-14234, 2003 | 567 | 2003 |
| Protein microarrays: meeting analytical challenges for clinical applications LA Liotta, V Espina, AI Mehta, V Calvert, K Rosenblatt, D Geho, ... Cancer cell 3 (4), 317-325, 2003 | 566 | 2003 |
| Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment P Iyengar, V Espina, TW Williams, Y Lin, D Berry, LA Jelicks, H Lee, ... The Journal of clinical investigation 115 (5), 1163-1176, 2005 | 476 | 2005 |
| Use of reverse phase protein microarrays and reference standard development for molecular network analysis of metastatic ovarian carcinoma KM Sheehan, VS Calvert, EW Kay, Y Lu, D Fishman, V Espina, J Aquino, ... Molecular & Cellular Proteomics 4 (4), 346-355, 2005 | 376 | 2005 |
| Protein microarrays: molecular profiling technologies for clinical specimens V Espina, AI Mehta, ME Winters, V Calvert, J Wulfkuhle, EF Petricoin III, ... Proteomics 3 (11), 2091-2100, 2003 | 308 | 2003 |
| Tumorigenic and metastatic activity of human thyroid cancer stem cells M Todaro, F Iovino, V Eterno, P Cammareri, G Gambara, V Espina, ... Cancer research 70 (21), 8874-8885, 2010 | 280 | 2010 |
| Phosphoprotein pathway mapping: Akt/mammalian target of rapamycin activation is negatively associated with childhood rhabdomyosarcoma survival EF Petricoin III, V Espina, RP Araujo, B Midura, C Yeung, X Wan, ... Cancer research 67 (7), 3431-3440, 2007 | 271 | 2007 |
| Protein microarray detection strategies: focus on direct detection technologies V Espina, EC Woodhouse, J Wulfkuhle, HD Asmussen, EF Petricoin III, ... Journal of immunological methods 290 (1-2), 121-133, 2004 | 267 | 2004 |
| Smart hydrogel particles: biomarker harvesting: one-step affinity purification, size exclusion, and protection against degradation A Luchini, DH Geho, B Bishop, D Tran, C Xia, RL Dufour, CD Jones, ... Nano letters 8 (1), 350-361, 2008 | 257 | 2008 |
| A portrait of tissue phosphoprotein stability in the clinical tissue procurement process V Espina, KH Edmiston, M Heiby, M Pierobon, M Sciro, B Merritt, S Banks, ... Molecular & cellular proteomics 7 (10), 1998-2018, 2008 | 244 | 2008 |
| Safety and biologic response of pre-operative autophagy inhibition in combination with gemcitabine in patients with pancreatic adenocarcinoma BA Boone, N Bahary, AH Zureikat, AJ Moser, DP Normolle, WC Wu, ... Annals of surgical oncology 22, 4402-4410, 2015 | 225 | 2015 |
| Laser capture microdissection technology V Espina, M Heiby, M Pierobon, LA Liotta Expert review of molecular diagnostics 7 (5), 647-657, 2007 | 217 | 2007 |
| Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy EF Petricoin III, VE Bichsel, VS Calvert, V Espina, M Winters, L Young, ... Journal of clinical oncology 23 (15), 3614-3621, 2005 | 198 | 2005 |
| Serum proteomics in cancer diagnosis and management KP Rosenblatt, P Bryant-Greenwood, JK Killian, A Mehta, D Geho, ... Annu. Rev. Med. 55, 97-112, 2004 | 192 | 2004 |
| A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer EM Posadas, MS Liel, V Kwitkowski, L Minasian, AK Godwin, MM Hussain, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2007 | 176 | 2007 |
| Reverse phase protein microarrays advance to use in clinical trials C Mueller, LA Liotta, V Espina Molecular oncology 4 (6), 461-481, 2010 | 166 | 2010 |
| A randomized phase II preoperative study of autophagy inhibition with high-dose hydroxychloroquine and gemcitabine/nab-paclitaxel in pancreatic cancer patients HJ Zeh, N Bahary, BA Boone, AD Singhi, JL Miller-Ocuin, DP Normolle, ... Clinical cancer research 26 (13), 3126-3134, 2020 | 162 | 2020 |
